UPDATE: Onyx Pharmaceuticals (ONXX) Sees Activity as FDA Briefing Docs Posted
Tweet
Share
E-mailGet Alerts ONXX Hot Sheet
Join SI Premium – FREE
(Updated - June 18, 2012 8:22 AM EDT)
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) is seeing volatility as FDA briefing documents have been posted. Link
Shares last traded down fractionally to $45.28, versus Friday's close of $45.98.
Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX) is seeing volatility as FDA briefing documents have been posted. Link
Shares last traded down fractionally to $45.28, versus Friday's close of $45.98.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump: nominate Heidi Overton, MD, PhD, as our next FDA commissioner
- Ck Hutch Seeks Over $1.5b For Destruction Of Panama Investments - Bloomberg
- SpaceX attempted to acquire AI coding startup Cognition - Bloomberg
Create E-mail Alert Related Categories
FDA, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
